• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昼夜节律性卡马西平毒性。

Circadian carbamazepine toxicity.

作者信息

Haefeli W E, Meyer P G, Lüscher T F

机构信息

Department of Internal Medicine, University Hospital, Basel, Switzerland.

出版信息

Epilepsia. 1994 Mar-Apr;35(2):400-2. doi: 10.1111/j.1528-1157.1994.tb02451.x.

DOI:10.1111/j.1528-1157.1994.tb02451.x
PMID:8156964
Abstract

Owing to marked fluctuations in plasma concentrations, circadian CNS toxicity (maximum in the early afternoon) occurred in a 69-year-old female patient being treated with an instant-release formulation of carbamazepine (CBZ). The neurologic syndrome was reversible after administration of the same daily dose as sustained-release formulation. This case illustrates the importance of correct timing of blood sampling to detect drug-induced toxicity and of use of sustained-release formulations in antiepileptic therapy with CBZ.

摘要

由于血浆浓度的显著波动,一名69岁接受速释型卡马西平(CBZ)治疗的女性患者出现了昼夜节律性中枢神经系统毒性(午后早些时候最为严重)。在给予相同每日剂量的缓释制剂后,神经综合征得以逆转。该病例说明了在卡马西平抗癫痫治疗中,正确选择采血时间以检测药物诱导的毒性以及使用缓释制剂的重要性。

相似文献

1
Circadian carbamazepine toxicity.昼夜节律性卡马西平毒性。
Epilepsia. 1994 Mar-Apr;35(2):400-2. doi: 10.1111/j.1528-1157.1994.tb02451.x.
2
Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.癫痫患儿血浆和唾液中卡马西平及卡马西平-10,11-环氧化物的昼夜变化:传统剂型与缓释剂型的比较
J Child Neurol. 1990 Apr;5(2):159-65. doi: 10.1177/088307389000500219.
3
Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.从速释卡马西平转换为缓释卡马西平后中枢神经系统耐受性的改善。
Acta Neurol Scand. 2004 Jun;109(6):374-7. doi: 10.1111/j.1600-0404.2004.00291.x.
4
Developmental and therapeutic pharmacology of antiepileptic drugs.抗癫痫药物的发育药理学与治疗药理学
Epilepsia. 2000;41 Suppl 9:2-6. doi: 10.1111/j.1528-1157.2000.tb02209.x.
5
Steady state concentrations and diurnal fluctuations of carbamazepine in patients after different slow release formulations.不同缓释制剂治疗后患者体内卡马西平的稳态浓度及昼夜波动情况。
Arzneimittelforschung. 1992 Mar;42(3):284-8.
6
Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults.新型抗癫痫和中枢神经系统药物RWJ-333369与卡马西平在健康成年人中的药代动力学相互作用研究。
Epilepsia. 2006 Nov;47(11):1830-40. doi: 10.1111/j.1528-1167.2006.00815.x.
7
Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.卡马西平及其环氧化物:难治性部分性癫痫患者增加卡马西平剂量后的疗效及副作用的开放性研究
Ther Drug Monit. 1994 Dec;16(6):537-40.
8
Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.卡马西平缓释胶囊与奥卡西平:漏服剂量对药物血浆浓度影响的计算机模拟
Curr Med Res Opin. 2005 Sep;21(9):1363-8. doi: 10.1185/030079905X59120.
9
The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence.从新生儿期至青春期儿童中卡马西平向卡马西平-10,11-环氧化物的代谢。
Neuropediatrics. 1994 Aug;25(4):214-6. doi: 10.1055/s-2008-1073024.
10
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.KOMET 试验:一项开放性、随机、两平行组、分层试验,比较左乙拉西坦、卡马西平控释片和丙戊酸钠缓释片作为单药治疗新诊断癫痫患者的有效性。
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29.

引用本文的文献

1
Carbamazepine extended-release capsules in bipolar disorder.卡马西平缓释胶囊治疗双相情感障碍。
Neuropsychiatr Dis Treat. 2006 Mar;2(1):3-11.